- Zacks•4 hours ago
Medical device major Medtronic plc's (MDT) Brain Therapies division is expected to get a boost from the recent U.S. FDA approval for its StealthStation Cranial Software.
- GlobeNewswire•6 hours ago
Sugar.IQ with Watson Cognitive App to Preview at Health 2.0 Conference DUBLIN and SANTA CLARA, Calif. - Sept. 27, 2016 - Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced ...
Medtronic plc (MDT)
NYSE - NYSE Real Time Price. Currency in USD
|Bid||86.71 x 400|
|Ask||86.72 x 200|
|Day's Range||85.73 - 86.78|
|52wk Range||64.95 - 89.27|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||33.71|
|Avg Vol (3m)||4,315,126|
|Dividend & Yield||1.72 (1.96%)|